CPT® Code 87517

The CPT® Code 87517 refers to a laboratory test specifically designed for the detection and quantification of the hepatitis B virus (HBV) through nucleic acid analysis, which can involve either DNA or RNA. This test is crucial for individuals who may be at risk for chronic HBV infection, as such infections significantly increase the likelihood of developing serious liver conditions, including cirrhosis and hepatocellular carcinoma. Hepatitis B virus can be transmitted through various means, including blood and body fluids, sexual contact, from mother to infant during childbirth, and through shared contaminated objects like needles, razors, and toothbrushes. The ability to detect HBV nucleic acid is particularly valuable in cases where hepatitis B surface Antigen (HBsAg) tests return negative results, providing essential prognostic information. To perform this test, a blood sample is collected, and the serum or plasma is analyzed. The methodology employed for this detection often involves real-time polymerase chain reaction (RT-PCR), a sophisticated technique that amplifies specific strands of HBV DNA or RNA. During this process, the targeted nucleic acid sequences are replicated and subsequently identified using DNA probes that are tagged with fluorescent or chemiluminescent markers, ensuring specificity to the target sequence. This advanced detection method allows for the identification of HBV DNA or RNA even at very low viral loads, as minimal as 20 IU/mL (116 copies/mL). The presence of these nucleic acids in the amplified sample can indicate ongoing low-level viral replication, suggesting an active HBV infection. CPT® Code 87517 is specifically utilized for the quantification of HBV DNA or RNA, providing a measurement of the viral load present in the sample. This quantitative assessment is critical for monitoring the progression of the disease and evaluating the effectiveness of treatment regimens. The use of quantitative or real-time PCR techniques allows for the generation of detailed reports that document the absolute or relative amounts of the detected nucleic acid sequences, thereby facilitating informed clinical decision-making regarding patient management.